FDA Approves Carboplatin Injection, 600 Mg - Initial Treatment Of Advanced Ovarian Carcinoma

... AmericanPharmaceutical Partners, Inc. (Nasdaq: APPX), today announced that it hasreceived approval from the U.S. Food and Drug Administration (FDA) for itsAbbreviated New Drug Application (ANDA) for Carboplatin Injection (liquidform) in a 600 mg multi-dose vial. Carboplatin is the generic equivalent ofBristol-Myers Squibb Company''s Paraplatin(R)... click link for more info. ...